| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 23,442 | 19,302 | ||
| Short-term investments | 37,184 | 60,012 | ||
| Prepaid expenses and other current assets | 5,890 | 5,943 | ||
| Total current assets | 66,516 | 85,257 | ||
| Property and equipment, gross | 3,179 | - | ||
| Less accumulated depreciation | 1,828 | - | ||
| Property and equipment, net | 1,351 | 1,497 | ||
| Long-term investments | 5,838 | 4,232 | ||
| Other assets | 9,018 | 4,334 | ||
| Total assets | 82,723 | 95,320 | ||
| Accounts payable | 6,583 | 4,902 | ||
| Payable and accrued liabilities due to related party | 0 | 40 | ||
| Term loan, current | 4,348 | 3,043 | ||
| Accrued expenses and other current liabilities | 16,791 | 10,863 | ||
| Total current liabilities | 27,722 | 18,848 | ||
| Term loan, non-current | 5,764 | 6,997 | ||
| Other non-current liabilities | 4,437 | 5,060 | ||
| Total liabilities | 37,923 | 30,905 | ||
| Common stock, 0.001 par value 1,000,000,000 shares authorized as of september 30, 2025 and december 31, 2024 53,577,566 and 53,052,912 shares issued and outstanding as of september 30, 2025 and december 31, 2024 respectively | 54 | 54 | ||
| Additional paid-in capital | 744,672 | 742,150 | ||
| Accumulated other comprehensive income | 43 | 36 | ||
| Accumulated deficit | -699,969 | -677,825 | ||
| Total stockholders equity | 44,800 | 64,415 | ||
| Total liabilities and stockholders equity | 82,723 | 95,320 | ||
ALX ONCOLOGY HOLDINGS INC (ALXO)
ALX ONCOLOGY HOLDINGS INC (ALXO)